Frontiers in Bioengineering and BiotechnologyMolecular BiologyPeer-reviewed journal article
Production of high-affinity glycosylated anti-mouse conjugated nanobodies in Pichia pastoris
Sofía OrioliiD, Javier SantosiD, Lorena Itatí IbañeziD, Cecilia D’AlessioiD
Abstract
Nanobodies (NBs) are small antibody fragments derived from camelid heavy-chain antibodies which represent the minimal functional domain capable of antigen recognition and binding. NB are ten times smaller than conventional antibodies, exhibit a compact structure and high stability, making them ideal for recombinant production. The eukaryotic unicellular system Pichia pastoris provides multiple advantages for protein expression, including the ability to perform several eukaryotic posttranslational modifications. In this work, we engineered a modular plasmid sequence that, through specific restriction enzyme cuts and ligations, codes the expression of a secreted anti-mouse kappa chain NB fused with various accessory peptides in P. pastoris. This system enables the incorporation of a plastic binding sequence, a histidine tag (Hisx6) for purification, the horseradish peroxidase (HRP) enzyme for chemiluminescence detection, or the biotinylatable AviTag sequence, in multiple combinations. We successfully expressed and purified anti-kappa NBs fused to a Hisx6-tag ({kappa}NB) and to HRP -Hisx6-tag ({kappa}NB-HRP), with subsequent structural and functional characterization revealing high affinity for mouse immunoglobulins. The {kappa}NB-kappa light chain domain complex was modeled showing a fitted surface interaction of CDR3 domain. The position of a glycan in the complex was modeled predicting that glycan addition would not affect the interaction surface. Accordingly, no functional differences were observed in {kappa}NB after deglycosylation, indicating that high mannose glycan addition has not interfered with its binding capability. Moreover, glycosylated {kappa}NB fused to HRP was expressed with retained HRP activity, and proved to be functional as a secondary antibody, demonstrating the systems versatility in producing NBs and conjugated NBs with posttraslational modification that may be required for diverse biotechnological applications.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 28th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Optimizing expression of Nanobody molecules in Pichia pastoris through co-expression of auxiliary proteins under methanol and methanol-free conditions
M. R. De Groeve, B. J. Laukens, P. G. Schotte·bioRxiv·Mar 31, 2023
- A toolbox of anti-mouse and rabbit IgG secondary nanobodies
T. Pleiner, M. Bates, D. Goerlich·bioRxiv·Oct 26, 2017
- Peptidisc-assisted hydrophobic clustering towards the production of multimeric and multispecific nanobody proteins
Yilun Chen, Franck Duong·BiochemistryPeer-reviewed·Jan 15, 2025
- Modular Nanobody Conjugates with Controlled Topology Using Genetically Encoded Non-canonical Amino Acids
Roman Adomanis, Nathan Phan, … Blaise R. Kimmel·bioRxiv·Nov 27, 2025
- Improvement of Antibody Affinity and Using PURE Ribosome Display and Microbial Secretion System
Monami Kihara, Rio Okuda, … Hideo Nakano·bioRxiv·Sep 13, 2024
- Yeast-based production platform for potent and stable heavy chain-only antibodies
Chiara Lonigro, Hannah Eeckhaut, … Nico Callewaert·bioRxiv·Mar 4, 2024